Major complications of angioaccess surgery.
Major complications of angioaccess surgery.
复制标题
血管通路手术的主要并发症。
DOI：
10.1097/00132586-199308000-00070
复制
发表时间：
1993
影响因子：
3
通讯作者：
J. Malone
中科院分区：
文献类型：
--
作者：
J. L. Ballard;T. Bunt;J. Malone
对一个机构在 4 年期间进行的血管通路手术进行了回顾性审查，以确定主要肢体或危及生命的并发症的发生频率。总共进行了 435 例血管介入手术，包括 81 例 Cimino-Brescia 瘘管、166 例聚四氟乙烯移植物和 111 例血栓切除/修复术。 53名患者因主要并发症进行了77次手术。此外，有五名患者因中央血液透析管置入的并发症而需要进行大血管修复或紧急开胸手术。血管外科医生的血管通路总病例量中的很大一部分（本系列的 18%）将用于修复主要并发症。院内死亡率（6 名患者，即 11%）和长期死亡率（12 名患者，即 23%）死亡率很高。虽然大多数并发症可以通过分流抢救术在不损失肢体的情况下修复，但一小部分患者（在我们的研究中为 3 名患者，即 4%）会出现长期衰弱症状。
Angioaccess procedures at one institution over a 4-year period were retrospectively reviewed to ascertain the frequency of major limb- or life-threatening complications. A total of 435 angioaccess procedures were performed, including 81 Cimino-Brescia fistulas, 166 polytetrafluoroethylene grafts, and 111 thrombectomy/revisions. There were 77 operations for major complications in 53 patients. In addition, five patients required major vascular repair or emergency thoracotomy for complications of central hemodialysis line placement. A significant portion (18% of this series) of the total angioaccess caseload of a vascular surgeon will be utilized in the repair of major complications. The in-hospital (6 patients, or 11%) and long-term (12 patients, or 23%) mortality rates are significant. Although most complications can be repaired without limb loss and with shunt salvage, a small percentage (in our study three patients, or 4%) will have debilitating long-term symptoms.